Capmatinib and paclitaxel combination: a novel strategy for overcoming challenges in triple-negative breast cancer treatment
{{output}}
Background: Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer (BC) with limited treatment options. Paclitaxel (PTX) is commonly used, but its effectiveness is hampered by resistance and metastasis. Th... ...
